Aditxt, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Aditxt, Inc. (ADTX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 17.38 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-15
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 17.38M shares, a 133.63% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 14.56M shares, a 270.65% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 13.83M shares, a 254.01% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 12.34M shares, a 223.45% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 6.90M shares, a 80.18% increase from fiscal 2019.
- Aditxt, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.83M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | 17.38M shares 10-Q · filed 2021-11-15 | 15.97M shares derived: average of 2 quarters · filed 2021-11-15 | 15.27M shares 10-Q · filed 2021-11-15 | 14.53M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | 14.56M shares 10-Q · filed 2021-08-12 | 14.20M shares 10-Q · filed 2021-08-12 | 13.58M shares derived: average of 3 quarters · filed 2021-08-12 | 12.04M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2021-03-31 | 13.83M shares 10-Q · filed 2021-05-12 | 13.08M shares derived: average of 2 quarters · filed 2021-05-12 | 11.20M shares derived: average of 3 quarters · filed 2021-11-15 | 9.38M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2020-12-31 | 12.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 9.89M shares derived: average of 2 quarters · filed 2021-11-15 | 7.90M shares derived: average of 3 quarters · filed 2021-11-15 | 6.90M shares 10-K · filed 2021-03-25 | |
| 2020-09-30 | 7.44M shares 10-Q · filed 2021-11-15 | 5.68M shares derived: average of 2 quarters · filed 2021-11-15 | 5.09M shares 10-Q · filed 2021-11-15 | 5.09M shares 10-Q · filed 2020-11-13 | 4.77M shares derived: average of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | 3.93M shares 10-Q · filed 2021-08-12 | 3.92M shares 10-Q · filed 2021-08-12 | 3.88M shares derived: average of 3 quarters · filed 2021-08-12 | 3.88M shares derived: average of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | 3.91M shares 10-Q · filed 2021-05-12 | 3.86M shares derived: average of 2 quarters · filed 2021-05-12 | 3.86M shares derived: average of 3 quarters · filed 2021-05-12 | 3.86M shares derived: average of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | 3.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 3.84M shares derived: average of 2 quarters · filed 2021-03-25 | 3.84M shares derived: average of 3 quarters · filed 2021-03-25 | 3.83M shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 3.87M shares 10-Q · filed 2020-11-13 | 3.85M shares derived: average of 2 quarters · filed 2020-11-13 | 3.84M shares 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | 3.84M shares 10-Q · filed 2020-08-13 | 3.82M shares 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |